Additionally, HuR bound to the transforming growth interacting factor mRNA 3′UTR and prevented it from degradation in response to arsenic trioxide in hepatocellular carcinoma, which suggests a connection between HuR function and arsenic trioxide resistance during anti-cancer therapy [161]. Here, ELAVL1 is linked to cancer.